Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
1.390
+0.020 (1.46%)
At close: Oct 8, 2025, 4:00 PM EDT
1.430
+0.040 (2.88%)
After-hours: Oct 8, 2025, 8:00 PM EDT
Oragenics Market Cap
Oragenics has a market cap or net worth of $5.74 million as of October 8, 2025. Its market cap has increased by 112.47% in one year.
Market Cap
5.74M
Enterprise Value
6.85M
1-Year Change
112.47%
Ranking
Category
Stock Price
$1.39
Market Cap Chart
Since February 27, 2004, Oragenics's market cap has increased from $1.60M to $5.74M, an increase of 258.55%. That is a compound annual growth rate of 6.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 5.70M | 26.67% |
Dec 31, 2024 | 4.50M | -68.97% |
Dec 29, 2023 | 14.50M | 17.89% |
Dec 30, 2022 | 12.30M | -76.30% |
Dec 31, 2021 | 51.90M | 89.42% |
Dec 31, 2020 | 27.40M | 13.69% |
Dec 31, 2019 | 24.10M | -4.74% |
Dec 31, 2018 | 25.30M | 118.10% |
Dec 29, 2017 | 11.60M | -56.23% |
Dec 30, 2016 | 26.50M | -51.55% |
Dec 31, 2015 | 54.70M | 69.88% |
Dec 31, 2014 | 32.20M | -62.43% |
Dec 31, 2013 | 85.70M | 18.53% |
Dec 31, 2012 | 72.30M | 1,125.42% |
Dec 30, 2011 | 5.90M | -65.29% |
Dec 31, 2010 | 17.00M | -37.50% |
Dec 31, 2009 | 27.20M | 186.32% |
Dec 31, 2008 | 9.50M | -17.39% |
Dec 31, 2007 | 11.50M | -50.00% |
Dec 29, 2006 | 23.00M | 253.85% |
Dec 30, 2005 | 6.50M | -88.25% |
Dec 31, 2004 | 55.30M | 3,356.25% |
Feb 27, 2004 | 1.60M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 764.32B |
Johnson & Johnson | 457.03B |
AbbVie | 410.57B |
UnitedHealth Group | 335.19B |
AstraZeneca | 266.44B |
Novo Nordisk | 265.74B |
Novartis AG | 257.26B |
Abbott Laboratories | 233.92B |